Literature DB >> 30851290

First experience of ribavirin postexposure prophylaxis for Nipah virus, tried during the 2018 outbreak in Kerala, India.

Sayantan Banerjee1, Vettakkara Kandy Muhammed Niyas1, Manish Soneja2, Areekkare Purayil Shibeesh3, Muhammed Basheer3, Rajeev Sadanandan4, Naveet Wig2, Ashutosh Biswas5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30851290     DOI： 10.1016/j.jinf.2019.03.005

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  5 in total

Review 1.  Antivirals targeting paramyxovirus membrane fusion.

Authors:  Erik M Contreras; Isaac Abrrey Monreal; Martin Ruvalcaba; Victoria Ortega; Hector C Aguilar
Journal:  Curr Opin Virol       Date:  2021-09-27       Impact factor: 7.090

Review 2.  The Immunobiology of Nipah Virus.

Authors:  Yvonne Jing Mei Liew; Puteri Ainaa S Ibrahim; Hui Ming Ong; Chee Ning Chong; Chong Tin Tan; Jie Ping Schee; Raúl Gómez Román; Neil George Cherian; Won Fen Wong; Li-Yen Chang
Journal:  Microorganisms       Date:  2022-06-06

Review 3.  Evolution of Nipah Virus Infection: Past, Present, and Future Considerations.

Authors:  Naomi Hauser; Alexis C Gushiken; Shivakumar Narayanan; Shyam Kottilil; Joel V Chua
Journal:  Trop Med Infect Dis       Date:  2021-02-14

Review 4.  Medical countermeasures against henipaviruses: a review and public health perspective.

Authors:  Raúl Gómez Román; Nadia Tornieporth; Neil George Cherian; Amy C Shurtleff; Maïna L'Azou Jackson; Debra Yeskey; Adam Hacker; Eric Mungai; Tung Thanh Le
Journal:  Lancet Infect Dis       Date:  2021-11-01       Impact factor: 25.071

5.  Predicting and designing therapeutics against the Nipah virus.

Authors:  Neeladri Sen; Tejashree Rajaram Kanitkar; Ankit Animesh Roy; Neelesh Soni; Kaustubh Amritkar; Shreyas Supekar; Sanjana Nair; Gulzar Singh; M S Madhusudhan
Journal:  PLoS Negl Trop Dis       Date:  2019-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.